Terminology Service for NFDI4Health
gp100:17-25 Peptide
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2765
A synthetic peptide vaccine consisting of amino acids 17 through 25 of the glycoprotein 100 (gp100) melanoma antigen. Vaccination with gp100_17-25 may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for gp100, resulting in decreased tumor growth. (NCI04) [ ]
Term info
Label
gp100:17-25 Peptide
Synonyms
- gp100:17-25 Peptide
Has Target
http://purl.obolibrary.org/obo/NCIT_C2386
Legacy Concept Name
gp100_17-25
NSC Code
699051
Preferred Name
gp100:17-25 Peptide
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C0674030
code
C2765
Term relations
Subclass of:
- Antineoplastic Vaccine
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation